Real World Experiences of the iNAP® Lite in OSA Adults in Taiwan
NCT ID: NCT03559322
Last Updated: 2019-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
76 participants
OBSERVATIONAL
2019-08-01
2021-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pivotal Study of the iNAP® in Adults With OSA
NCT03544463
Pilot Study of Negative Pressure Sleep Therapy System to Treat Obstructive Sleep Apnea
NCT02324790
A Post-marketing Surveillance of the Negative Pressure Sleep Therapy System to Treat Obstructive Sleep Apnea
NCT02698059
The Taiwan OSA Study
NCT07302685
Is the Daytime Sleepiness Based on Epworth Sleepiness Scale a Good Way to Assess Taiwanese With Suspected Obstructive Sleep Apnea.
NCT04631783
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iNAP® Lite Sleep Therapy System
Class II intraoral devices for snoring and/or obstructive sleep apnea
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with have severe respiratory disorders such as pulmonary diseases, pneumothorax, etc.
* Patients with loose teeth or advanced periodontal disease.
* Patients with pathologically low blood pressure.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Somnics, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chung-Chu Chen, Ph.D.
Role: STUDY_CHAIR
Somnics, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Chia-Mo Lin, M.D.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Lin HY, Nien CT, Chen CC, Hong II, Lin C, Lin CM. Optimizing treatment of the novel intra-oral negative pressure for obstructive sleep apnea. Sleep Breath. 2025 Feb 28;29(1):115. doi: 10.1007/s11325-025-03263-w.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
iNAP®-TW-1702
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.